Product Information

BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $8.4146 per ML under NDC 24208046415. Its NADAC has been published 54 times since Nov 5, 2025.

FDA first approved this application on Aug 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRINZOLAMIDE 1% EYE DROPS

brinzolamide
$8.4146per ML

Strength

10 mg/mL

NDC

24208046415

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204884

FDA Approved

8/18/2021

TE Code

AB

On Market Since

3/31/2022

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 54 times since Nov 5, 2025, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4146 per ML
All-time high$14.3013 (Feb 11, 2026)
All-time low$8.4146 (Oct 21, 2026)
52-week high$14.3013
52-week low$8.4146
Median price$10.3303
Average price$11.0655
Largest weekly change+14.5% (Jan 21, 2026)
Weeks tracked54
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

-11.2%

3M

-18.1%

6M

-16.5%

1Y

-32.3%

3Y

N/A

5Y

N/A

All

-32.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $8.4146 per ML (NDC 24208046415), effective Nov 11, 2026.

How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 32.3%. It has been tracked across 54 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?

Since Nov 5, 2025, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $8.4146 (Oct 21, 2026) to a high of $14.3013 (Feb 11, 2026), with a median of $10.3303 per ML.

Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $7.9504 per ML — about 6% below BRINZOLAMIDE 1% EYE DROPS.

Who manufactures BRINZOLAMIDE 1% EYE DROPS?

BRINZOLAMIDE 1% EYE DROPS (NDC 24208046415) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.